ALISON D SILVA is listed as an executive officer and director on 7 SEC Form D filings by 1 issuer between Aug 2015 and May 2018: Cotinga Pharmaceuticals Inc. (London, Ontario, Canada (as filed: A6) — biotechnology — 2015–2018; $1.58M reported sold to 6 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside DAVID SANDERSON (7 shared filings), DOUGLAS S ALEXANDER (7 shared filings), GENE KELLY (7 shared filings), JOHN C DRAKE (7 shared filings), BRUNO MARUZZO (6 shared filings) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around ALISON. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for ALISON D SILVA and found 6 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.